Monday, May 20, 2019

Kairos, TCA Back Biopharmaceuticals Startup

Kairos Ventures, a Los Angeles-based venture capital investor, as well as Southern California's Tech Coast Angels, have backed a clinical stage biopharmaceuticals company in a Series B funding. According to Actuate Therapeutics, it raised $21.7M in a Series B funding. Actuate, which is based in Texas, is developing treatments for cancer and

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.